# SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE

> **NCT02221778** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Sao Paulo** · enrollment: 25 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT02221778
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-08
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02221778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02221778, "SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT02221778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*